Po box 100287, nsmc, auckland, new zealand

PO Box 100287, NSMC, Auckland, New Zealand
Ph: (09) 489 7090 Fax: (09) 489 7091
Material Safety Data Sheet
Date of Issue: 20 June 2002
A granular insecticide for the control of various pests in turf, gardens and otheroutdoor areas.
Physical Description/Properties
Chemical Entity
Health Effects:
Chlorpyrifos is an organo-phosphate insecticide and will inhibit cholineesterase. Symptoms of overexposure to the
active constituent may include headaches, dizziness, incoordination, muscle twitching, tremors, nausea, abdominal
cramps, diarrhoea, sweating, constrictive pupils, blurred vision, salivation, tightness of the chest, excessive urination
and convulsions.
The acute oral toxicity of the active constituent is high with reported LD50 measurements for the active at 115mg/Kg.
Because of the low levels of active constituent in this product the risk of serious poisoning by ingestion is low.
EyesMay irritate eyes.
SkinThe acute dermal toxicity for the active constituent is low and the formulation makes the risk of poisoning by this routevery small. The product may cause some skin irritation after prolonged contact and will irritate broken skin.
InhaledThe risk of poisoning by dust inhalation is low but the dust will irritate the mucous membranes and cause sinuousdiscomfort. Prolonged exposure to the product may cause headaches and other discomfort as a result of the presence ofpetroleum solvents.
Rats and mice which were administered the active ingredient in long term studies showed no increase in tumours
compared to the control. Studies in rats and rabbits indicates that the active constituent does not cause birth defects or
infere with reproduction. There is no known evidence of genetic change or accumulation of the active constituent in the
First Aid:
If swallowed contact a doctor or the National Poisons Centre (0800 764 766)
If in eyes hold eyelids open, flood with water for at least 15 minutes and see a doctor if irritation persists.
Wash skin with soap and water.
Remove victim to fresh air and seek medical advice if effects persist. If breathing difficulties become acute give
Advice to Doctor:
Chlorpyrifos is a cholinesterase inhibitor. Atropine by injection or Atrovent/ipratropium by airway puffs are the
desirable antidotes. Oximes such as 2 PAM/protopam may be therapeutic if used early but only in conjunction with
Exposure Standards:
Time weighted average for chlorpyrifos is 0.2 mg/m3. Exposure standards for nuisance dusts should also be observed.
Engineering Controls:
Use only in well ventilated areas.
Personal Protection:
When using the product wear rubber gloves. Avoid breathing dust by using an appropriate dust mask. Wash hands
after use.
Product is not highly flammable although the small amount of petroleum solvent will support short term combustion.
Storage and Transport:
Store in a cool dry place in sealed original containers away from direct sunlight. Store away from food, feed or any
items intended for human or animal consumption. Keep out of reach of children. Product is not classified as a
dangerous good under current transport regulations.
Spills and Disposal:
Spills should be swept or vacuumed. Avoid breathing dust. Personal protective equipment as outlined above should be
utilised in cleaning up all spills. The best method of disposal of spills is to use the product in accordance with the label
directions. If this is not possible dispose of at an appropriate local authority landfill.
Fire/Explosion Hazard:
If involved in a fire the product may emit potentially harmful gases. Fire fighters should wear appropriate breathing
apparatus and all non essential personal should be kept downwind.
Chlorpyrifos is toxic to birds, fish and bees. The product should be irrigated immediately after use to move the granulesfrom the surface to reduce the risk of poisoning to foraging birds. Do not apply in any manner which may result in thegranules washing into waterways. Chlorpyrifos does not bioaccumulate in animal systems.
NOTICE: Information for this product is believed to be reliable, however buyer and user assume all risk of use,handling and storage whether in accordance with directions or not. Environmental Health Products and its agents giveno guarantee or warranty of any kind expressed or implied concerning the use of this product and will not accept anyresponsibility whatsoever whether in contract or tort for any loss including consequential loss arising out of the use ofthis product or caused by this product

Source: http://www.philproof.co.nz/msds/antstop_nz_msds.pdf

Holdings per currency fix income 20021231.xls

Fixed-Income Holdings Per Currency As at 31 December 2002 Security Nominal amount (QC) Market Value (SEK) Clean Value(SEK) EUR Belgium Kingdom Government 5.50 2017-09-28 Italy Buoni Poliennali Del Tesoro 6 2031-05-01 7 169 309 285 6 958 443 680 GBP United Kingdom Government 9 2011-07-12 United Kingdom Government 5.75 2009-12-07United Kingdom Government 6.25 2010-11-

Microsoft word - face_neck_brow_lift.doc

Post-Operative Care for Face, Neck and/or Brow Lift At Home After Procedure: • On the first night, sleep with your head elevated on 2 pillows or on a • You may climb stairs or go to the bathroom with assistance. • It is normal to be drowsy from the anesthetics. Try to eat only a light, soft meal the evening following your procedure. Avoid excessive chewing. • Swelling, and tightness of

© 2010-2018 Modern Medicine